CatalystMarker
← board

CDIOW

distress 5/10 · elevated risk
$0.01-6%today-65% from 52w high
cdio.ai15 employeesFounded 2017Chicago, IL
Revenue
pre-revenue
Liquidity
$0M
Runway
Shares 1y
+68%

Price & events

-62.4% over 6M
$0.01$0.02$0.03Mar 26May 26Jul 2612k
CatalystRating changeDilutionFinancingdashed = today
-6.2%
1D
-21.1%
1W
-52.4%
1M
-52.4%
3M
6M
1Y
2Y
5Y
-62.4%
All

Overview

Market Cap
$35.51K
Volume
1.20K
52 Week Range
$0.01 – $0.03
Total Shares
2.96M
Float Shares
2.83M
RVOL
1.70x
Beta
2.18

Pipeline · 0 trials · 0 upcoming

ReadoutPhaseDrugIndicationEnrollStatus
No pipeline trials tracked.

Catalyst news & presentations · 0

  • No catalyst news yet.

Approved drugs (0)

  • none — clinical-stage

Capital structure — dilution & financing

Shares out: 2,959,469 · 2 offerings/1y · 0 PIPEs
🔒 Positioning — Pro
Short interest / days-to-cover, insider buys & sells.
Upgrade to Pro
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to Pro

Wall St ratings

no consensus
  • no recent rating changes

Competitors

  • none identified

Recent news

  • none

Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.